Drug Database
Back to search

Netherlands· NL-59001ca248fd

Angeliq, 1 mg/2 mg filmomhulde tabletten

A drospirenon und estrogen product containing drospirenon + estradiol 0,5-water, registered in Netherlands by Bayer B.V.. The same ATC class is registered in 8 of our 19 countries.

ATC G03FA17

Checked against CBG-MEB (Netherlands) on

Informational only — not a medical device.

SOURCE REGISTER · NLCBG-MEB (Netherlands)normalisedAngeliq, 1 mg/2 mg filmomhulde tablet…ATCG03FA17REGISTER NO.NL-59001ca248fdPACKS LISTED1CHECKEDSeptember 29, 2026
Compare price across countriesPer daily dose · free accountAsk the assistant about drospirenon + estradiol 0,5-waterAnswers with sources · free accountCheck interactionsSeverity free · mechanism on Growth

Where it is registered

Drospirenon und estrogen is registered in 8 of 19 countries.

Countries holding a registration under ATC G03FA17 (drospirenon und estrogen), each read from that country’s own register.

  • This record: Netherlands, from CBG-MEB (Netherlands)
  • 5 of them publish a price we can compare per daily dose
Search drospirenon und estrogen products by name

Drospirenon und estrogen · ATC G03FA17

8 / 19 countries

  • Belgiumprice
  • Canada
  • Czechiaprice
  • Finlandprice
  • Ireland
  • Italyprice
  • Netherlands
  • Switzerlandprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

CBG-MEB (Netherlands)
Active substance
DROSPIRENON + ESTRADIOL 0,5-WATER
Manufacturer
Bayer B.V.
Country
Netherlands (NL)
ATC code
G03FA17
ATC class
Drospirenon und Estrogen
Reimbursed
Not published by this register
Source register
CBG-MEB (Netherlands)
Last checked
September 29, 2026

Packs & prices · 1

  • cbg_meb_id
    27505

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

12 interactions on record for drospirenon und estrogen.

Mechanism, severity and management for each pair, from a commercially licensed source — included with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan
Check drospirenon und estrogen against other medicinesHow interaction checks work

Drospirenon und estrogen · interactions on record

12 records

12 more interactions with mechanism and management, from a commercially licensed source.

Sign in to check
Mechanism and what to do, in the interaction check
Interaction register. Grades as the source publishes them.

Same medicine, other countries

Drospirenon und estrogen in 10 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All drospirenon und estrogen products

Authorised across Europe · EMA

The same active substance is authorised in 16 EEA countries. Names it is sold under:

  • Belgium · Angeliq, Klimedix
  • Czechia · Angeliq, Paosonelle
  • Germany · Angeliq, Klimedix
  • Estonia · Angeliq
  • Spain · Angeliq
  • Finland · Angeliq
  • Croatia · Angeliq
  • Ireland · Angeliq
  • Italy · Angeliq, Paosonelle
  • Lithuania · Angeliq
  • Luxembourg · Angeliq
  • Latvia · Angeliq, Klimedix
  • Malta · Angeliq
  • Poland · Angeliq
  • Portugal · Angeliq, Klimedix
  • Slovenia · Angeliq

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of CBG-MEB (Netherlands). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/30b5fc2b-df10-49ff-b991-0712c7bda271
GET /v1/drugs/30b5fc2b-df10-49ff-b991-0712c7bda271?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Filmomhulde tablet",
  "route": "Oraal gebruik",
  "soort": "RVG",
  "source": "cbg_meb",
  "smpc_url": "https://www.geneesmiddeleninformatiebank.nl/smpc/h27505_smpc.pdf",
  "strength": null,
  "atc_label": "Drospirenone And Estrogen",
  "detail_url": "https://www.geneesmiddeleninformatiebank.nl/nl/rvg27505",
  "excipients": [
    "HYPROMELLOSE (E 464)",
    "IJZEROXIDE ROOD  (E 172)",
    "LACTOSE 1-WATER",
    "MACROGOL 6000",
    "MAGNESIUMSTEARAAT (E 470b)",
    "MAÏSZETMEEL",
    "POVIDON K 25 (E 1201)",
    "TALK (E 553b)",
    "TITAANDIOXIDE (E 171)",
    "ZETMEEL, GEMODIFICEERD (MODIFICATIE ONBEKEND) (E 1440)"
  ],
  "substances": [
    "DROSPIRENON",
    "ESTRADIOL 0,5-WATER"
  ],
  "leaflet_url": "https://www.geneesmiddeleninformatiebank.nl/bijsluiters/h27505.pdf",
  "authorised_at": "2002/12/11",
  "procedure_number": "NL/H/0380/001",
  "dispensing_status": "Uitsluitend recept",
  "registration_number": "27505",
  "additional_monitoring": "N"
}
API referenceMCP serverPlans

See everything about drospirenon und estrogen.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it freeOpen in the console